12 Month Price Forecast For ACB
Distance to ACB Price Forecasts
ACB Price Momentum
๐ค Considering Aurora Cannabis (ACB)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 10, 2025 1:38 PM UTC
ACB Analyst Ratings & Price Targets
Based on our analysis of 7 Wall Street analysts, ACB has a consensus that is neutral. The median price target is $0.00, with forecasts ranging from $0.00 to $0.00. Currently, there are 3 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
With ACB currently trading at $6.03, the median price forecast suggests a -100.0% downside. The most optimistic forecast comes from Pablo Zuanic at Zuanic & Associates, projecting a -100.0% downside, while Pablo Zuanic at Zuanic & Associates provides the most conservative target, suggesting a -100.0% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ACB Analyst Consensus
ACB Price Target Range
Latest ACB Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ACB.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Jun 27, 2024 | Zuanic & Associates | Pablo Zuanic | Neutral | Initiates | $0.00 |
Jun 16, 2023 | CIBC | John Zamparo | Neutral | Maintains | $1.00 |
Jun 15, 2023 | Canaccord Genuity | Matt Bottomley | Hold | Maintains | $0.80 |
Feb 13, 2023 | CIBC | John Zamparo | Neutral | Maintains | $1.75 |
Sep 21, 2022 | Piper Sandler | Michael Lavery | Neutral | Maintains | $3.00 |
Sep 28, 2021 | MKM Partners | Bill Kirk | Neutral | Upgrade | $0.00 |
Dec 18, 2020 | BMO Capital | Tamy Chen | Underperform | Downgrade | $9.00 |
Nov 25, 2020 | Cowen & Co. | Outperform | Initiates | $0.00 | |
Nov 25, 2020 | Bank of America | Neutral | Downgrade | $0.00 | |
Nov 25, 2020 | B of A Securities | Neutral | Downgrade | $0.00 | |
Nov 25, 2020 | Stifel | Sell | Downgrade | $0.00 | |
Nov 25, 2020 | Needham | Hold | Initiates | $0.00 | |
Nov 25, 2020 | Piper Sandler | Neutral | Maintains | $0.00 | |
Nov 25, 2020 | Jefferies | Buy | Initiates | $0.00 | |
Nov 25, 2020 | Stifel Nicolaus | Hold | Initiates | $0.00 | |
Nov 25, 2020 | MKM Partners | Sell | Initiates | $0.00 | |
Nov 25, 2020 | Seaport Global | Neutral | Initiates | $0.00 | |
Nov 25, 2020 | Piper Jaffray | Neutral | Maintains | $0.00 | |
Nov 25, 2020 | Ladenburg Thalmann | Neutral | Downgrade | $0.00 | |
Nov 25, 2020 | Desjardins | Buy | Initiates | $0.00 |
Stocks Similar to Aurora Cannabis Inc
The following stocks are similar to Aurora Cannabis based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Aurora Cannabis Inc (ACB) Financial Data
Aurora Cannabis Inc has a market capitalization of $331.03M with a P/E ratio of 31.7x. The company generates $207.14M in trailing twelve-month revenue with a -14.7% profit margin.
Revenue growth is +28.5% quarter-over-quarter, while maintaining an operating margin of -1.7% and return on equity of -5.8%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

Aurora Cannabis Inc (ACB) Company Overview
About Aurora Cannabis Inc
Produces and sells cannabis and related products.
Aurora Cannabis Inc. generates revenue through the cultivation, distribution, and sale of a wide range of cannabis and cannabis-derived products, targeting both medical and recreational markets. The company operates two main segments: Canadian Cannabis, which focuses on the domestic market, and Plant Propagation, supplying vegetables and ornamental plants. Aurora also offers patient support services and has a diverse portfolio of brands catering to various consumer preferences.
Founded in 2013 and headquartered in Edmonton, Canada, Aurora Cannabis has a significant presence in both the Canadian and international cannabis markets. Its extensive product offerings include dried cannabis, oils, capsules, edibles, and CBD products, appealing to a broad customer base. The company continues to expand its brand portfolio and enhance its market reach.
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,073
CEO
Mr. Miguel Martin
Country
Canada
IPO Year
2014
Website
www.auroramj.comAurora Cannabis Inc (ACB) Latest News & Analysis
Aurora Cannabis reported record Q3/FY2025 results with high sales, margins, and free cash flow. Cash equivalents rose to $180.2 million, and the company remains debt-free amid strong European sales growth.
Aurora Cannabis' record Q3 results and strong cash position indicate robust financial health, driving confidence in growth and stability, especially in the expanding European market.
Aurora Cannabis Inc (ACB) reported Q3 fiscal 2025 net revenue of CA$88.2 million, up from CA$64.4 million in the same quarter last year.
Aurora Cannabis's revenue growth signals strong demand and operational improvements, potentially boosting investor confidence and stock performance in the cannabis sector.
Aurora Cannabis Inc. will hold its Q3 2025 earnings conference call on February 5, 2025, at 8:00 AM ET, featuring key executives and analysts from various financial institutions.
Aurora Cannabis's Q3 2025 earnings call will provide key insights into its financial performance and strategic direction, impacting stock valuations and investor sentiment.
Aurora Cannabis (NASDAQ: ACB) reported Q3 fiscal 2025 net revenue of $88.2M, up 37% YoY, with net income of $31.2M, up 282% YoY. Free cash flow reached $27.4M, maintaining a debt-free status.
Aurora Cannabis' strong revenue growth, record net income, and positive cash flow signal robust operational performance, enhancing investor confidence and potential for future growth.
Aurora Cannabis Inc. (NASDAQ: ACB, TSX: ACB) has entered a strategic supply agreement with SNDL Inc. for premium cannabis flower from SNDL's New Brunswick facility.
The supply agreement between Aurora Cannabis and SNDL enhances Aurora's product offerings and strengthens its supply chain, potentially boosting revenue and market position in the competitive cannabis sector.
Aurora Cannabis Inc. (ACB) reported quarterly earnings of $0.06 per share, exceeding estimates of $0.04 and improving from a loss of $0.20 per share last year.
Aurora Cannabis' earnings beat estimates and show a significant turnaround from last year's loss, indicating improved financial health and potential for future growth.
Frequently Asked Questions About ACB Stock
What is Aurora Cannabis Inc's (ACB) stock forecast for 2025?
Analyst forecasts for Aurora Cannabis Inc (ACB) are not currently available. The stock is trading at $6.03.
Is ACB stock a good investment in 2025?
According to current analyst ratings, ACB has 3 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $6.03. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for ACB stock?
Price predictions from Wall Street analysts for ACB are not currently available. The stock is trading at $6.03.
What is Aurora Cannabis Inc's business model?
Aurora Cannabis Inc. generates revenue through the cultivation, distribution, and sale of a wide range of cannabis and cannabis-derived products, targeting both medical and recreational markets. The company operates two main segments: Canadian Cannabis, which focuses on the domestic market, and Plant Propagation, supplying vegetables and ornamental plants. Aurora also offers patient support services and has a diverse portfolio of brands catering to various consumer preferences.
What is the highest forecasted price for ACB Aurora Cannabis Inc?
Price targets from Wall Street analysts for ACB are not currently available. The stock is trading at $6.03.
What is the lowest forecasted price for ACB Aurora Cannabis Inc?
Price targets from Wall Street analysts for ACB are not currently available. The stock is trading at $6.03.
What is the overall ACB consensus from analysts for Aurora Cannabis Inc?
The overall analyst consensus for ACB is neutral. Out of 7 Wall Street analysts, 3 rate it as Buy, 3 as Hold, and 0 as Sell.
How accurate are ACB stock price projections?
Stock price projections, including those for Aurora Cannabis Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.